Active substance
Alendronic acid
- SFDA 18
- US FDA 21
- Health Canada 16
- US price lines 6
- NHS prices 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| ALENDRO | 70 mg | Tablet · Oral use | 4 Blister | SAR 43.65 | Generic · Prescription | Jamjoom Pharmaceuticals Factory Company | Valid |
| ALENDRONATE SANDOZ 70MG F/C TABLET | 70 mg | Film-coated tablet · Oral use | 4 Blister | SAR 28.50 | NCE · Prescription | SANDOZ | Valid |
| DROLATE 70 MG FILM COATED TABLETS | 70 mg | Tablet · Oral use | 4 Blister | SAR 28.50 | Generic · Prescription | The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM) | Valid |
| FOSAMAX ONCE WEEKLY 70MG TAB | 70 mg | Tablet · Oral use | 4 Blister | SAR 45.95 | NCE · Prescription | N.V. Organon | Valid |
| LENDOMAX 70 MG TABLETS | 70 mg | Tablet · Oral use | 4 Blister | SAR 35.15 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Valid |
| ALENDOCAN 70 MG TABLETS | 70 mg | Tablet · Oral use | 4 Blister | SAR 18.70 | Generic · Prescription | APOTEX | Withdrawn by MAH · Not Marketed |
| BINOSTO 70 mg EFFERVESCENT TABLET | 70 mg | Effervescent tablet · Oral use | 4 Blister | SAR 28.50 | NCE · Prescription | Jazeera Pharmaceutical Industries (JPI) | Withdrawn by MAH · Not Marketed |
| BONAMAX 35MG TABLETS | 35 mg | Tablet · Oral use | 4 Blister | SAR 38.55 | Generic · Prescription | RIYADH PHARMA | Withdrawn by MAH · Not Marketed |
| BONAMAX 70MG TABLETS | 70 mg | Tablet · Oral use | 4 Blister | SAR 28.50 | Generic · Prescription | RIYADH PHARMA | Withdrawn by MAH · Not Marketed |
| FOSAMAX 10MG TAB | 10 mg | Tablet · Oral use | 28 Blister | SAR 146.40 | NCE · Prescription | MERCK SHARP & DOHME | Withdrawn by MAH · Not Marketed |
| FOZANATE 70MG TABLET | 70 mg | Tablet · Oral use | 4 Blister | SAR 28.50 | NCE · Prescription | GLOBAL PHARMA | Withdrawn by MAH · Not Marketed |
| OSTEO- MEPHA 70MG F.C. TABLETS | 70 mg | Tablet · Oral use | 2 Blister | SAR 14.25 | Generic · Prescription | ACINO PHARMA AG | Withdrawn by MAH · Not Marketed |
| OSTEO- MEPHA 70MG F.C. TABLETS | 70 mg | Tablet · Oral use | 4 Blister | SAR 28.50 | Generic · Prescription | ACINO PHARMA AG | Withdrawn by MAH · Not Marketed |
| OSTEODENS 70MG TABLETS | 70 mg | Tablet · Oral use | 4 Blister | SAR 31.65 | Generic · Prescription | SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO | Withdrawn by MAH · Not Marketed |
| OSTEOMAX 70 MG TABLETS | 70 mg | Tablet · Oral use | 4 Blister | SAR 28.50 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Withdrawn by MAH · Not Marketed |
| OSTEVE 35MG TABLETS | 35 mg | Tablet · Oral use | 4 Blister | SAR 65.35 | Generic · Prescription | SPIMACO ADDWAEIH | Withdrawn by MAH · Not Marketed |
| OSTEVE 70 MG TABLETS | 70 mg | Tablet · Oral use | 4 Blister | SAR 39.05 | Generic · Prescription | COOPER PHARMA | Withdrawn by MAH · Not Marketed |
| OSTEVE 70 MG TABLETS | 70 mg | Tablet · Oral use | 4 Blister | SAR 130.75 | Generic · Prescription | SPIMACO ADDWAEIH | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
BREAST CANCER MET. HORMONAL-ADVERSE REACTION MANAGEMENT; BREAST CANCER MET. HORMONAL-SUPPORTIVE CARE; BREAST CANCER MET.HER-2 +VE-ADVERSE REACTION MANAGEMENT; BREAST CANCER TARGET THERAPY-ADVERSE REACTION MANAGEMENT; BURKITT`S LYMPHOMA; CASTLEMAN DISEASE; DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL); FOLLICULAR LYMPHOMA; HYPERPARATHYRODISM; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; MULTIPLE MYELOMA-HYPERCALCEMIA OF MALIGNANCY; OSTEOPOROSIS; PROSTATE CANCER; SPINAL MUSCULAR ATROPHY - MAINTENANCE OF BONE HEALTH
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| FOSAMAX | EQ 70MG BASE | tablet · oral | ORGANON | Prescription | 29 Sep 1995 |
| ALENDRONATE SODIUM | EQ 5MG BASE; EQ 10MG BASE; EQ 35MG BASE; EQ 40MG BASE; EQ 70MG BASE | tablet · oral | CIPLA | Prescription | 4 Aug 2008 |
| ALENDRONATE SODIUM | EQ 35MG BASE; EQ 40MG BASE; EQ 70MG BASE | tablet · oral | WATSON LABS | Prescription | 4 Aug 2008 |
| ALENDRONATE SODIUM | EQ 10MG BASE; EQ 35MG BASE; EQ 70MG BASE | tablet · oral | AUROBINDO PHARMA | Prescription | 4 Aug 2008 |
| ALENDRONATE SODIUM | EQ 5MG BASE; EQ 10MG BASE; EQ 35MG BASE; EQ 70MG BASE | tablet · oral | SUN PHARM | Prescription | 10 Sep 2008 |
| ALENDRONATE SODIUM | EQ 5MG BASE; EQ 10MG BASE; EQ 35MG BASE; EQ 70MG BASE | tablet · oral | HANGZHOU BINJIANG | Prescription | 24 Sep 2009 |
| ALENDRONATE SODIUM | EQ 70MG BASE/75ML | solution · oral | HIKMA PHARMS | Prescription | 25 Feb 2013 |
| ALENDRONATE SODIUM | EQ 70MG BASE/75ML | solution · oral | NOVITIUM PHARMA | Prescription | 11 May 2023 |
| ALENDRONATE SODIUM | EQ 10MG BASE; EQ 35MG BASE; EQ 40MG BASE; EQ 70MG BASE | tablet · oral | IPCA LABS LTD | Prescription | 4 Jun 2024 |
| ALENDRONATE SODIUM | EQ 70MG BASE/75ML | solution · oral | PRECISION DOSE INC | Prescription | 2 Sep 2026 |
| FOSAMAX | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; EQ 35MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | ORGANON | Discontinued | 29 Sep 1995 |
| FOSAMAX | EQ 70MG BASE/75ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | solution · oral | MERCK | Discontinued | 17 Sep 2003 |
| ALENDRONATE SODIUM | EQ 5MG BASE; EQ 10MG BASE; EQ 35MG BASE; EQ 40MG BASE; EQ 70MG BASE | tablet · oral | IMPAX LABS INC | Discontinued | 6 Feb 2008 |
| ALENDRONATE SODIUM | EQ 70MG BASE; EQ 35MG BASE | tablet · oral | TEVA PHARMS | Discontinued | 6 Feb 2008 |
| ALENDRONATE SODIUM | EQ 5MG BASE; EQ 10MG BASE; EQ 35MG BASE; EQ 70MG BASE | tablet · oral | RISING | Discontinued | 4 Aug 2008 |
| ALENDRONATE SODIUM | EQ 5MG BASE; EQ 10MG BASE; EQ 35MG BASE; EQ 70MG BASE | tablet · oral | APOTEX | Discontinued | 4 Aug 2008 |
| ALENDRONATE SODIUM | EQ 35MG BASE; EQ 70MG BASE | tablet · oral | MYLAN | Discontinued | 4 Aug 2008 |
| ALENDRONATE SODIUM | EQ 35MG BASE; EQ 70MG BASE; EQ 5MG BASE; EQ 10MG BASE | tablet · oral | CHARTWELL RX | Discontinued | 4 Aug 2008 |
| ALENDRONATE SODIUM | EQ 5MG BASE; EQ 10MG BASE; EQ 40MG BASE; EQ 35MG BASE; EQ 70MG BASE | tablet · oral | CHARTWELL RX | Discontinued | 22 Apr 2009 |
| ALENDRONATE SODIUM | EQ 5MG BASE; EQ 10MG BASE; EQ 35MG BASE; EQ 70MG BASE | tablet · oral | JUBILANT CADISTA | Discontinued | 18 Feb 2010 |
| BINOSTO | EQ 70MG BASE | tablet, effervescent · oral | RADIUS | Discontinued | 12 Mar 2012 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| ACH-ALENDRONATE | 02381486 | 10 MG | TABLET · ORAL | ACCORD HEALTHCARE INC |
| ACH-ALENDRONATE | 02381494 | 70 MG | TABLET · ORAL | ACCORD HEALTHCARE INC |
| AG-ALENDRONATE SODIUM | 02506327 | 70 MG | TABLET · ORAL | ANGITA PHARMA INC. |
| ALENDRONATE | 02299712 | 70 MG | TABLET · ORAL | SIVEM PHARMACEUTICALS ULC |
| ALENDRONATE | 02352966 | 70 MG | TABLET · ORAL | SANIS HEALTH INC |
| ALENDRONATE-70 | 02303078 | 70 MG | TABLET · ORAL | PRO DOC LIMITEE |
| APO-ALENDRONATE | 02248730 | 70 MG | TABLET · ORAL | APOTEX INC |
| AURO-ALENDRONATE | 02388545 | 10 MG | TABLET · ORAL | AURO PHARMA INC |
| AURO-ALENDRONATE | 02388553 | 70 MG | TABLET · ORAL | AURO PHARMA INC |
| FOSAMAX | 02245329 | 70 MG | TABLET · ORAL | ORGANON CANADA INC. |
| JAMP ALENDRONATE SODIUM | 02500175 | 70 MG | TABLET · ORAL | JAMP PHARMA CORPORATION |
| M-ALENDRONATE | 02529394 | 70 MG | TABLET · ORAL | MANTRA PHARMA INC |
| NRA-ALENDRONATE | 02523116 | 70 MG | TABLET · ORAL | NORA PHARMA INC |
| PMS-ALENDRONATE-FC | 02284006 | 70 MG | TABLET · ORAL | PHARMASCIENCE INC |
| RIVA-ALENDRONATE | 02270889 | 70 MG | TABLET · ORAL | LABORATOIRE RIVA INC. |
| TEVA-ALENDRONATE | 02261715 | 70 MG | TABLET · ORAL | TEVA CANADA LIMITED |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | ALENDRONATE SOD 70 MG/75 ML | $0.68257 | per ML | 23 Sep 2026 |
| US NADAC | ALENDRONATE SODIUM 10 MG TAB | $0.11123 | per EA | 23 Sep 2026 |
| US NADAC | ALENDRONATE SODIUM 35 MG TAB | $0.28125 | per EA | 23 Sep 2026 |
| US NADAC | ALENDRONATE SODIUM 70 MG TAB | $0.25627 | per EA | 23 Sep 2026 |
| US NADAC | BINOSTO 70 MG EFFERVESCENT TAB | $71.226 | per EA | 23 Sep 2026 |
| US NADAC | FOSAMAX 70 MG TABLET | $38.70415 | per EA | 1 Jan 2026 |
| NHS Drug Tariff | Alendronic acid 70mg effervescent tablets sugar free | £11.60 | 4 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Alendronic acid 70mg tablets | £0.79 | 4 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Alendronic acid 70mg/100ml oral solution unit dose sugar free | £21.13 | 4 unit dose | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Combinations containing Alendronic acid
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.